Laboratory Work-Up for Myocarditis
Cardiac troponin (troponin T or I) should be obtained in all patients with suspected myocarditis, along with a 12-lead ECG and transthoracic echocardiogram 1. These three tests form the essential initial diagnostic triad and carry Class C level of evidence recommendations from the American Heart Association.
Essential Laboratory Tests
Cardiac Biomarkers (Priority Testing)
Troponin T or I: This is the single most important laboratory test and should be obtained immediately 1. However, recognize a critical limitation: troponin was elevated in only 34% of patients with histologically confirmed acute myocarditis who had symptoms for approximately 1 month 1. High-sensitivity troponin assays may improve detection rates 1.
Natriuretic peptides (BNP or NT-proBNP): Should be assessed according to heart failure management guidelines 1. These are particularly elevated in patients with isolated myocarditis (median NT-proBNP 2043 pg/mL) compared to those with concomitant myopathy (median 606 pg/mL) 2.
Creatine kinase (CK): Essential to distinguish isolated myocarditis from myocarditis with concomitant myopathy. Patients with both conditions have markedly elevated CK (median 3441 U/L vs 232 U/L in isolated myocarditis) 2.
Inflammatory Markers (Limited Utility)
Important caveat: There are no clinically available specific blood tests to confirm myocarditis 1.
ESR and C-reactive protein: Can be elevated but are neither sensitive nor specific 3, 1. These should be obtained but cannot rule in or rule out the diagnosis.
Complete blood count with differential: Obtain to evaluate for eosinophilia, which suggests hypersensitivity myocarditis from drugs/vaccines or hypereosinophilic syndrome 1. An elevated eosinophil count fundamentally changes management toward immunosuppression.
Tests to AVOID
Routine viral serology testing should NOT be performed 3. A prospective study of 124 patients demonstrated that virus serology had only 9% sensitivity and 25% positive predictive value when compared to endomyocardial biopsy with PCR 4. Only 4% of patients showed serological evidence matching the virus detected on biopsy 4. This represents futile testing that does not change management.
Biomarker Pattern Recognition
The biomarker profile helps distinguish clinical phenotypes:
Isolated myocarditis pattern: Higher NT-proBNP, lower troponin (median 75 ng/L), normal-to-mildly elevated CK, more likely to present with heart failure 2
Myocarditis with myopathy pattern: Markedly elevated troponin (median 716 ng/L), very high CK (median 3441 U/L), lower NT-proBNP, more likely to present with arrhythmias 2
Clinical Integration
The diagnosis requires ≥1 clinical presentation AND ≥1 diagnostic criterion from different categories 1. For asymptomatic patients, ≥2 diagnostic criteria must be met 1.
Common Pitfall
Do not rely solely on troponin elevation. Given its sensitivity of only 34% in subacute presentations 1, a normal troponin does not exclude myocarditis, particularly if symptoms have been present for weeks. In this scenario, proceed directly to cardiac MRI if clinical suspicion remains high.
Special Populations
In patients with suspected immune checkpoint inhibitor-related myocarditis, obtain both troponin and CK simultaneously, as the presence of concomitant myopathy (CK >1000 U/L) predicts different complications—primarily arrhythmias rather than heart failure 2.